We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$8.89B
AUM Growth
-$1.49B
Cap. Flow
-$1.55B
Cap. Flow %
-17.42%
Top 10 Hldgs %
47.67%
Holding
1,012
New
106
Increased
478
Reduced
302
Closed
124

Top Buys

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$37.3M
2
MMP
Magellan Midstream Partners, L.P.
MMP
+$31.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
NEM icon
Newmont
NEM
+$27.4M
5
CMI icon
Cummins
CMI
+$24.3M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$430M
2
JPM icon
JPMorgan Chase
JPM
+$168M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$132M
4
YUM icon
Yum! Brands
YUM
+$105M
5
PFE icon
Pfizer
PFE
+$92.8M

Sector Composition

Rank Sector Weight
1 Energy 59.33%
2 Technology 6.01%
3 Healthcare 4.63%
4 Consumer Discretionary 3.72%
5 Financials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRE
351
DELISTED
Duke Realty Corp.
DRE
$1.05M 0.01%
+15,982
New +$923K
JNJ icon
352
Johnson & Johnson
JNJ
$635B
$1.03M 0.01%
6,023
-175,282
-97% -$28.7M
PRAX icon
353
Praxis Precision Medicines
PRAX
$9.07B
$1.02M 0.01%
3,460
-210
-6% -$61.6K
STOK icon
354
Stoke Therapeutics
STOK
$1.82B
$1.02M 0.01%
42,571
-2,463
-5% -$58.8K
VNDA icon
355
Vanda Pharmaceuticals
VNDA
$312M
$1.01M 0.01%
64,469
-3,724
-5% -$64.9K
GRTS
356
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1.01M 0.01%
+78,678
New +$871K
SRRK icon
357
Scholar Rock
SRRK
$5.71B
$1.01M 0.01%
40,623
-1,606
-4% -$44.3K
ALXO icon
358
ALX Oncology
ALXO
$273M
$1.01M 0.01%
46,872
-2,576
-5% -$111K
GOSS icon
359
Gossamer Bio
GOSS
$66.5M
$1M 0.01%
88,487
-4,649
-5% -$55.2K
TRMK icon
360
Trustmark
TRMK
$2.73B
$1M 0.01%
30,835
-3,648
-11% -$119K
KDNY
361
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$999K 0.01%
61,221
+6,318
+12% +$89.9K
FULT icon
362
Fulton Financial
FULT
$4.7B
$980K 0.01%
57,662
-5,012
-8% -$82.6K
KLRS
363
Kalaris Therapeutics
KLRS
$88.7M
$975K 0.01%
3,278
-192
-6% -$89.1K
AGEN
364
Agenus
AGEN
$249M
$957K 0.01%
+15,144
New +$1.19M
KZR
365
DELISTED
Kezar Life Sciences
KZR
$951K 0.01%
5,688
-219
-4% -$24.7K
AU icon
366
AngloGold Ashanti
AU
$40.3B
$940K 0.01%
44,810
-8,813
-16% -$172K
GFI icon
367
Gold Fields
GFI
$29.2B
$940K 0.01%
85,541
-12,209
-12% -$122K
META icon
368
Meta Platforms (Facebook)
META
$1.51T
$938K 0.01%
2,788
-5,879
-68% -$1.95M
UNIT
369
Uniti Group
UNIT
$2.63B
$937K 0.01%
+66,849
New +$891K
ODFL icon
370
Old Dominion Freight Line
ODFL
$48.5B
$932K 0.01%
5,200
+252
+5% +$42.5K
IMGO
371
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$920K 0.01%
+38,802
New +$899K
QCOM icon
372
Qualcomm
QCOM
$176B
$911K 0.01%
4,980
+2,405
+93% +$385K
VXRT
373
DELISTED
Vaxart
VXRT
$909K 0.01%
+144,972
New +$990K
NSC icon
374
Norfolk Southern
NSC
$78.8B
$907K 0.01%
3,046
+395
+15% +$110K
SPG icon
375
Simon Property Group
SPG
$74.5B
$906K 0.01%
+5,668
New +$865K
13 14
15
16 17

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, ALPS Advisors held 1,012 positions worth $8.89B, down 14% from $10.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $1.55B in Q4 2021, closing 124 positions and reducing 302 holdings. Its most notable exit was Berkshire Hathaway Class A, an estimated $430M position sold in full.

By sector, the portfolio is most concentrated in Energy at 59% of assets, up from 51% a quarter earlier, followed by Technology and Healthcare.

Against the trend, ALPS Advisors opened a new position in Bristol-Myers Squibb worth $29.6M.

  • ALPS Advisors's largest Q4 2021 buy was Bristol-Myers Squibb: 474,459 shares worth $29.6M.
  • ALPS Advisors added most to Energy Transfer Partners in Q4 2021, an estimated $37.3M increase.
  • ALPS Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $168M.
  • ALPS Advisors fully exited Berkshire Hathaway Class A in Q4 2021, selling an estimated $430M.
  • ALPS Advisors's ten largest holdings make up 48% of its $8.89B portfolio in Q4 2021.
  • ALPS Advisors opened 106 new positions and closed 124 in Q4 2021.
  • ALPS Advisors's portfolio value fell 14% quarter-over-quarter to $8.89B.

Based on ALPS Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.